ActLouvika® 140 mg Capsule
GENERIC NAME: Ibrutinib 140 mg
THERAPEUTIC CLASS: Antineoplastic Agent
INDICATIONS & DOSAGE: It is used to treat the following blood cancers in adults:
- Mantle cell lymphoma (MCL)
- Chronic lymphocytic leukemia (CLL)
- Waldenstrom’s macroglobulinemia (WM)
STORAGE: Store below 30° C. Protected from light and moisture.
PACK SIZE: 1 bottle containing 90 capsules
DOSAGE & ADMINISTRATION:
- Mantle cell lymphoma (MCL): The recommended dose of ActLouvika is 560 mg once a day.
- Chronic lymphocytic leukemia (CLL)/ Waldenstrom’s macroglobulinemia (WM): The recommended dose of ActLouvika is 420 mg once a day.
